An Act providing for insurance coverage for routine patient care costs when an insured, enrollee or subscriber participates in approved cancer clinical trials; establishing the Pennsylvania Cancer Clinical Trial Review Board to adjudicate disputes involving third-party reimbursement for routine patient care costs incurred in association with approved cancer clinical trials; and providing for hearings and appeals.